Skip to main content

Charles River Laboratories Intl(CRL-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Charles River Laboratories Intl

251 BALLARDVALE STREET
WILMINGTON MA 01887 USA
P: 781-222-6000
http://www.criver.com

Profile

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.

Key Executives

NameTitle
James C. FosterCEO/Chairman of the Board/Director/President

More from The Globe